Hyaluronic Acid Enhances Cell Migration and Invasion Via the YAP1/TAZ-RHAMM Axis in Malignant Pleural Mesothelioma

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Dec 8

PMID 29212185

Citations 9

Authors

Wataru Shigeeda

Masahiko Shibazaki

Shinji Yasuhira

Tomoyuki Masuda

Tatsuo Tanita

Yuka Kaneko

Tatsuhiro Sato

Yoshitaka Sekido

Chihaya Maesawa

Affiliations

Soon will be listed here.

Abstract

Most malignant mesotheliomas (MPMs) frequently show activated forms of Yes-associated protein 1 (YAP1) and transcriptional co-activator with PDZ-binding motif (TAZ), which transcriptionally regulates the receptor for hyaluronic acid-mediated motility (RHAMM). As RHAMM is involved in cell migration and invasion in various tumors, we speculated that hyaluronic acid (HA) in pleural fluid might affect the progression of mesothelioma by stimulating cell migration and invasion through RHAMM. The level of RHAMM expression was decreased by YAP1/TAZ knockdown, and conversely increased by forced expression of the active form of YAP1, suggesting that RHAMM was regulated by YAP1/TAZ in MPM cells. Cell migration and invasion were also decreased by YAP1/TAZ or RHAMM knockdown. Notably, HA treatment increased cell motility and invasion, and this was abolished by RHAMM knockdown, suggesting that HA may augment local progression of MPM cells via RHAMM. Furthermore, treatment with fluvastatin, which regulates RHAMM transcription by modulating YAP1/TAZ activity, decreased the motility and invasion of MPM cells. Collectively, these data suggest that HA is an "unfavorable" factor because it promotes malignancy in mesothelioma and that the YAP1/TAZ-RHAMM axis may have potential value as a therapeutic target for inhibition of disease progression in MPM.

Citing Articles

Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy.

Pashkina E, Bykova M, Berishvili M, Lazarev Y, Kozlov V Cells. 2025; 14(2).

PMID: 39851489 PMC: 11764402. DOI: 10.3390/cells14020061.

Friend or foe? The elusive role of hepatic stellate cells in liver cancer.

Cogliati B, Yashaswini C, Wang S, Sia D, Friedman S Nat Rev Gastroenterol Hepatol. 2023; 20(10):647-661.

PMID: 37550577 PMC: 10671228. DOI: 10.1038/s41575-023-00821-z.

Interactions between Nitric Oxide and Hyaluronan Implicate the Migration of Breast Cancer Cells.

Alsharabasy A, Glynn S, Farras P, Pandit A Biomacromolecules. 2022; 23(9):3621-3647.

PMID: 35921128 PMC: 9472231. DOI: 10.1021/acs.biomac.2c00545.

Study of hsa_circRNA_000121 and hsa_circRNA_004183 in papillary thyroid microcarcinoma.

Bai C, Yang W, Ouyang R, Li Z, Zhang L Open Life Sci. 2022; 17(1):726-734.

PMID: 35891968 PMC: 9281586. DOI: 10.1515/biol-2022-0080.

Mechanical Cues Affect Migration and Invasion of Cells From Three Different Directions.

Mierke C Front Cell Dev Biol. 2020; 8:583226.

PMID: 33043017 PMC: 7527720. DOI: 10.3389/fcell.2020.583226.

References

Voelcker V, Gebhardt C, Averbeck M, Saalbach A, Wolf V, Weih F . Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol. 2007; 17(2):100-7. DOI: 10.1111/j.1600-0625.2007.00638.x. View

Halder G, Dupont S, Piccolo S . Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat Rev Mol Cell Biol. 2012; 13(9):591-600. DOI: 10.1038/nrm3416. View

Moroishi T, Park H, Qin B, Chen Q, Meng Z, Plouffe S . A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 2015; 29(12):1271-84. PMC: 4495398. DOI: 10.1101/gad.262816.115. View

Zhang N, Bai H, David K, Dong J, Zheng Y, Cai J . The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell. 2010; 19(1):27-38. PMC: 2925178. DOI: 10.1016/j.devcel.2010.06.015. View

Lei Q, Zhang H, Zhao B, Zha Z, Bai F, Pei X . TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol. 2008; 28(7):2426-36. PMC: 2268418. DOI: 10.1128/MCB.01874-07. View

Turley E, Noble P, Bourguignon L . Signaling properties of hyaluronan receptors. J Biol Chem. 2001; 277(7):4589-92. DOI: 10.1074/jbc.R100038200. View

Schmaus A, Klusmeier S, Rothley M, Dimmler A, Sipos B, Faller G . Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis. Br J Cancer. 2014; 111(3):559-67. PMC: 4119989. DOI: 10.1038/bjc.2014.332. View

Ma Y, Yang Y, Wang F, Wei Q, Qin H . Hippo-YAP signaling pathway: A new paradigm for cancer therapy. Int J Cancer. 2014; 137(10):2275-86. DOI: 10.1002/ijc.29073. View

Touil Y, Igoudjil W, Corvaisier M, Dessein A, Vandomme J, Monte D . Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis. Clin Cancer Res. 2013; 20(4):837-46. PMC: 4387277. DOI: 10.1158/1078-0432.CCR-13-1854. View

10.

Lesley J, He Q, Miyake K, Hamann A, HYMAN R, Kincade P . Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med. 1992; 175(1):257-66. PMC: 2119065. DOI: 10.1084/jem.175.1.257. View

11.

Zhao Y, Khanal P, Savage P, She Y, Cyr T, Yang X . YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway. Cancer Res. 2014; 74(16):4493-503. DOI: 10.1158/0008-5472.CAN-13-2712. View

12.

Gemba K, Fujimoto N, Aoe K, Kato K, Takeshima Y, Inai K . Treatment and survival analyses of malignant mesothelioma in Japan. Acta Oncol. 2012; 52(4):803-8. DOI: 10.3109/0284186X.2012.709948. View

13.

Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B . Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol. 2015; 17(9):1218-27. PMC: 6186417. DOI: 10.1038/ncb3216. View

14.

Wu A, Li J, Wu K, Mo Y, Luo Y, Ye H . LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression. Biomed Pharmacother. 2016; 82:290-7. DOI: 10.1016/j.biopha.2016.04.008. View

15.

Wu R, Huang L, Zhao H, Geng X . Hyaluronic acid in digestive cancers. J Cancer Res Clin Oncol. 2016; 143(1):1-16. DOI: 10.1007/s00432-016-2213-5. View

16.

Pettersson T, Froseth B, Riska H, Klockars M . Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest. 1988; 94(5):1037-9. DOI: 10.1378/chest.94.5.1037. View

17.

Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J . The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 2010; 24(11):1106-18. PMC: 2878649. DOI: 10.1101/gad.1903310. View

18.

Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T . LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011; 71(3):873-83. DOI: 10.1158/0008-5472.CAN-10-2164. View

19.

Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J . The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell. 2008; 14(3):377-87. PMC: 2292673. DOI: 10.1016/j.devcel.2008.01.006. View

20.

Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141(1):52-67. PMC: 2862057. DOI: 10.1016/j.cell.2010.03.015. View